全国肺癌筛查计划中低剂量胸部CT计算机辅助判读的变异性:各机构前瞻性判读与回顾性中心判读的比较
研究纳入全国肺癌筛查计划的3353例基线低剂量胸部CT,比较14家机构20名放射科医生使用计算机辅助检测与半自动分割系统的前瞻性判读与单名放射科医生在中心实验室的回顾性判读。中心判读的阳性率更高(Lung-RADS 27.3% vs 20.0%,NELSON 37.0% vs 23.1%,均p<.001),机构间变异性更低(CV 0.12 vs 0.30,p=.003;CV 0.12 vs 0.25,p=.014)。结论认为机构间判读变异主要源于计算机辅助系统的使用方式不同。
要点
- 机构判读阳性率跨度大:Lung-RADS 7.5–43.3%,NELSON 11.4–45.0%。
- 中心回顾性判读阳性率更高但机构间变异更小(CV 0.12)。
- 变异部分源于计算机辅助系统的不同使用方式。
核心结论
- 全国肺癌筛查计划中,不同机构对低剂量胸部CT的判读存在相当大的变异性,部分由计算机辅助系统的不同使用方式导致。
- 中心实验室回顾性判读降低了变异性,但提高了阳性率。
研究设计与样本
- 研究纳入全国肺癌筛查计划的连续基线低剂量胸部CT共3353例。
- 机构判读由14家机构的20名放射科医生使用计算机辅助检测和半自动分割系统进行。
- 中心回顾性判读由单名放射科医生使用相同系统重新判读所有低剂量胸部CT,记录任何≥3 mm的非钙化结节,不随意排除半自动分割结果以减少放射科医生的主观干预。
- 阳性结果(需额外随访低剂量胸部CT或诊断性操作)在判读时初步按肺CT筛查报告和数据系统(Lung-RADS)分类,同时回顾性应用荷兰-比利时肺癌筛查试验(NELSON)的容积标准进行分类。
- 阳性率的变异性采用变异系数(CV)评估。
诊断标准与关键数值
- 机构判读中,按Lung-RADS的阳性率范围为7.5%至43.3%,按NELSON的阳性率范围为11.4%至45.0%。
- 中心判读的Lung-RADS阳性率为27.3%,机构判读为20.0%(p<.001)。
- 中心判读的NELSON阳性率为37.0%,机构判读为23.1%(p<.001)。
- 按Lung-RADS,中心判读的机构间变异CV为0.12,机构判读为0.30(p=.003)。
- 按NELSON,中心判读的机构间变异CV为0.12,机构判读为0.25(p=.014)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the degree of variability in computer-assisted interpretation of low-dose chest CTs (LDCTs) among radiologists in a nationwide lung cancer screening (LCS) program, through comparison with a retrospective interpretation from a central laboratory.
MATERIALS AND METHODS: Consecutive baseline LDCTs (n = 3353) from a nationwide LCS program were investigated. In the institutional reading, 20 radiologists in 14 institutions interpreted LDCTs using computer-aided detection and semi-automated segmentation systems for lung nodules. In the retrospective central review, a single radiologist re-interpreted all LDCTs using the same system, recording any non-calcified nodules ≥ 3 mm without arbitrary rejection of semi-automated segmentation to minimize the intervention of radiologist's discretion. Positive results (requiring additional follow-up LDCTs or diagnostic procedures) were initially classified by the lung CT screening reporting and data system (Lung-RADS) during the interpretation, while the classifications based on the volumetric criteria from the Dutch-Belgian lung cancer screening trial (NELSON) were retrospectively applied. Variabilities in positive rates were assessed with coefficients of variation (CVs).
RESULTS: In the institutional reading, positive rates by the Lung-RADS ranged from 7.5 to 43.3%, and those by the NELSON ranged from 11.4 to 45.0% across radiologists. The central review exhibited higher positive rates by Lung-RADS (20.0% vs. 27.3%; p < .001) and the NELSON (23.1% vs. 37.0%; p < .001), and lower inter-institution variability (CV, 0.30 vs. 0.12, p = .003 by Lung-RADS; CV, 0.25 vs. 0.12, p = .014 by the NELSON) compared to the institutional reading.
CONCLUSION: Considerable inter-institution variability in the interpretation of LCS results is caused by different usage of the computer-assisted system.
KEY POINTS: • Considerable variability existed in the interpretation of screening LDCT among radiologists partly from the different usage of the computerized system. • A retrospective reading of low-dose chest CTs in the central laboratory resulted in reduced variability but an increased positive rate.
引用
- Hwang EJ, Goo JM, Kim HY, et al. Variability in interpretation of low-dose chest CT using computerized assessment in a nationwide lung cancer screening program: comparison of prospective reading at individual institutions and retrospective central reading. Eur Radiol. 2020. PMID: 33123794. doi:10.1007/s00330-020-07424-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。